Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation

JAMA

Volumn 275, Issue 9, 1996, Pages 699-703

  Greenberg, E Robert ^a   Baron, John A ^a   Karagas, Margaret R ^a   Stukel, Therese A ^a   Nierenberg, David W ^a   Stevens, Marguerite M ^a   Mandel, Jack S ^b   Haile, Robert W ^c  

^a NORRIS COTTON CANCER CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK;

EID: 0030071655     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.9.699     Document Type: Article

References (30)

1. National Research Council, Committee on Diet and Health, Food and Nutrition Board, Commission on Life Sciences. Diet and Health: Implications for Reducing Chromic Disease Risk. Washington, DC: National Academy Press; 1989.
2. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer, I: epidemiology. Cancer Causes Control. 1991;2:325-357.
3. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer. 1992;18:1-29.
4. Dwyer J. Health aspects of vegetarian diets. Am J Clin Nutr. 1988;48:712-738.
5. Riemersma RA, Wood DA, Macintyre CCA, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet. 1991;337:1-5.
6. Gaziano JM, Hennekens CH. The role of betacarotene in the prevention of cardiovascular disease. Ann N Y Acad Sci. 1994;691:148-155.
7. Morris DL, Kritchevsky SB, Davis CE. Serum carotenoids and coronary heart disease. JAMA. 1994;272:1439-1441.
8. Kardinaal AF, Kok FJ, Ringstad J, et al. Antioxidants in adipose tissue and risk of myocardial infarction. Lancet. 1993;342:1379-1384.
9. Jha P, Flather M, Lonn E, Farkouh M, Yusof S. The antioxidant vitamins and cardiovascular disease. Ann Intern Med. 1995;123:860-872.
10. Kohlmeier L, Hastings SB. Epidemiologie evidence of a role of carotenoids in cardiovascular disease prevention. Am J Clin Nutr. 1995;62:1370S-1376S.
11. Pandey DK, Shekelle R, Selwyn BJ, Tangney C, Stamler J. Dietary vitamin C and β-carotene and risk of death in middle-aged men. Am J Epidemiol. 1995;142:1269-1278.
12. Halliwell B, Oxidation of low-density lipoproteins: questions of initiation, propagation, and the effect of antioxidants. Am J Clin Nutr. 1995;61: 670S-677S.
13. Gerster H. Potential role of beta-carotene in the prevention of cardiovascular disease. Int J Vitam Nutr Res. 1991;61:277-291.
14. Halliwell E. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet. 1994;344:721-724.
15. Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Wiztum JL. Effect of dietary antioxidant combinations in humans: protection of LDL by vitamin E but not by beta-carotene. Arterioscler Thromb. 1993;13:590-600.
16. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029-1035.
17. van Poppel G, Goldbohm RA. Epidemiologic evidence for β-carotene and cancer prevention. Am J Clin Nutr. 1995;62:1393S-1402S.
18. Hennekens CH. Buring JE, Peto R. Antioxidant vitamins-benefits not yet proved. N Engl J Med. 1994;330:1080-1081.
19. Hankinson SE, Stampfer MJ. All that glitters is not beta carotene. JAMA. 1994;272:1455-1456.
20. Greenberg ER, Baron JA, Tosteson TD, et al for the Polyp Prevention Study Group. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med. 1994;331:141-147.
21. Greenberg ER, Baron JA, Stukel TA, et al for the Skin Cancer Prevention Study Group. A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. N Engl J Med. 1990; 323:789-795.
22. Greenberg ER, Baron JA, Stevens MM, et al. The Skin Cancer Prevention Study: design of a clinical trial of beta-carotene among persons at high risk for non-melanoma skin cancer. Control Clin Trials. 1989;10:153-166.
23. Greenberg ER. Carotenoids, cigarette smoking, and mortality risk. Ann N Y Acad Sci 1993; 691:120-126.
24. Nierenberg D. Serum and plasma beta-carotene levels measured with an improved method of high performance liquid chromatography. J Chromatogr. 1985;339:278-284.
25. Lee ET. Statistical Methods for Survival Data Analysis. Belmont, Calif: Lifetime Learning Publications; 1980.
26. Cox DR, Oakes D. Analysis of Survival Data. New York, NY: Chapman & Hall; 1984.
27. Byers T, Perry G. Dietary carotenes, vitamin C, and vitamin E as protective antioxidants in human cancers. Annu Rev Nutr. 1992;12:139-509.
28. Cantilena LR, Stukel TA, Greenberg ER, Nann S, Nierenberg DW. Diurnal and seasonal variation of five carotenoids measured in human serum. Am J Clin Nutr. 1992;55:659-663.
29. Willett WC, Stampfer MJ, Underwood BA, Speizer FE, Rosner B, Hennekens CH. Validation of a dietary questionnaire with plasma carotenoid and alpha-tocopherol levels. AJM J Clin Nutr. 1983; 38:631-639.
30. Campbell DR, Gross MD, Martini MC, Grandits GA, Slavin JL, Potter JD. Plasma carotenoids as biomarkers of vegetable and fruit intake. Cancer Epidemiol Biomarkers Prev. 1994;3:493-500.